This company has been marked as potentially delisted and may not be actively trading. NASDAQ:NVDQ (NVDQ) (NVDQ) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisDividendHeadlinesOptions ChainTrendsBuy This Stock About (NVDQ) Stock (NASDAQ:NVDQ) 30 days 90 days 365 days Advanced Chart Get (NVDQ) alerts:Sign Up Key Stats Today's Range$1.12▼$1.1850-Day Range N/A52-Week Range$5.84▼$12.74Volume14.98 million shsAverage Volume797,205 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield4.70%Price TargetN/AConsensus RatingN/A Company Overview NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases. Read More Receive NVDQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (NVDQ) and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NVDQ Stock News HeadlinesT-Rex 2X Inverse NVIDIA Daily Target ETFJune 20, 2025 | marketwatch.comRBC Launches RCLO ETF, Bringing Actively Managed CLO Exposure to Canadian InvestorsJune 11, 2025 | theglobeandmail.com“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druckenmiller — just raised nearly $1 billion in funding. Early backers believe it could be one of the most impactful breakthroughs of our lifetime. Whitney Tilson calls it “Helios” — and says a tiny Massachusetts firm sits at the center of what could become a global investment megatrend. If he’s right, this could mark the start of a seismic shift in how the world powers its future. | Stansberry Research (Ad)CEO Clips - North American Iron: Securing America’s Steel Future SustainablyJune 4, 2025 | theglobeandmail.comPrime Mining: Expanding a High-Grade Gold and Silver Resource in MexicoMay 30, 2025 | theglobeandmail.comEquiton: Delivering consistent returns through private multi-residential propertiesMay 30, 2025 | theglobeandmail.comCEO Clips - Cascadia Minerals Opens New Copper-Gold Frontier in the YukonMay 15, 2025 | theglobeandmail.comCEO Clips - Sitka Gold Builds on Yukon Discovery with Expanded Resource and New DrillingMay 15, 2025 | theglobeandmail.comSee More Headlines NVDQ Stock Analysis - Frequently Asked Questions How were (NVDQ)'s earnings last quarter? (NVDQ) (NASDAQ:NVDQ) released its quarterly earnings results on Wednesday, May, 3rd. The medical research company reported ($0.72) earnings per share for the quarter, missing the consensus estimate of ($0.63) by $0.09. The medical research company earned $21.08 million during the quarter, compared to the consensus estimate of $20.12 million. When did (NVDQ)'s stock split? Shares of (NVDQ) reverse split on the morning of Tuesday, July 16th 2024.The 1-3 reverse split was announced on Tuesday, July 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 16th 2024. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. Who are (NVDQ)'s major shareholders? Top institutional investors of (NVDQ) include Belvedere Trading LLC. What other stocks do shareholders of (NVDQ) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (NVDQ) investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Athabasca Oil (ATH), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX) and Accenture (ACN). Company Calendar Last Earnings5/03/2017Today9/09/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:NVDQ CIK1173293 Webnovadaq.com Phone+1-905-6293822FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:NVDQ) was last updated on 9/10/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWall Street Legend Issues Urgent AI Stock WarningChaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...Chaikin Analytics | SponsoredUnlock Friday's Full Potential: Two Simple Sentences that put profits in investors’ pocketsMost traders stick to the same routine each week. But a little-known market strategy has quietly delivered a 9...Eagle Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (NVDQ) Please log in to your account or sign up in order to add this asset to your watchlist. Share (NVDQ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.